LVOQX
Price
$17.07
Change
+$0.12 (+0.71%)
Updated
Jul 3 closing price
Net Assets
1.14B
VMCPX
Price
$383.04
Change
+$2.26 (+0.59%)
Updated
Jul 3 closing price
Net Assets
185.28B
Interact to see
Advertisement

LVOQX vs VMCPX

Header iconLVOQX vs VMCPX Comparison
Open Charts LVOQX vs VMCPXBanner chart's image
Lord Abbett Value Opportunities R2
Price$17.07
Change+$0.12 (+0.71%)
VolumeN/A
Net Assets1.14B
Vanguard Mid Cap Index InstitutionalPlus
Price$383.04
Change+$2.26 (+0.59%)
VolumeN/A
Net Assets185.28B
LVOQX vs VMCPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LVOQX vs. VMCPX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVOQX is a Buy and VMCPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 185B vs. LVOQX (1.14B). VMCPX pays higher dividends than LVOQX: VMCPX (1.54) vs LVOQX (0.00). LVOQX was incepted earlier than VMCPX: LVOQX (18 years) vs VMCPX (15 years). LVOQX (1.54) is less costly to investors than VMCPX (0.03). LVOQX is a more actively managed with annual turnover of: 33.00 vs. VMCPX (16.00). LVOQX has a lower initial minimum investment than VMCPX: LVOQX (0) vs VMCPX (100000000). VMCPX annual gain was more profitable for investors over the last year : 17.65 vs. LVOQX (-1.10). VMCPX return over 5 years is better than : 73.80 vs. LVOQX (12.82).
LVOQXVMCPXLVOQX / VMCPX
Total Expense Ratio1.540.035,133%
Annual Report Gross Expense Ratio1.540.035,133%
Fund Existence18 years15 years-
Gain YTD-1.6717.631-22%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.14B185B1%
Annual Yield % from dividends0.001.54-
Returns for 1 year-1.1017.65-6%
Returns for 3 years10.2043.1424%
Returns for 5 years12.8273.8017%
Returns for 10 years-14.11127.62-11%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNR3.400.17
+5.26%
Burning Rock Biotech Limited
TAC10.990.36
+3.39%
TransAlta Corp
BXP68.830.56
+0.82%
BXP Inc.
ISPC0.99-0.01
-1.00%
iSpecimen Inc
NKTR24.76-0.77
-3.02%
Nektar Therapeutics